ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
1.3K |
555K |
3 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
1.3K |
555K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
1.3K |
555K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
1.3K |
555K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
1.3K |
555K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
1.3K |
555K |
3 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Trading Volume: ZERO
|
|
Gan_Gans
|
14 |
4.8K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
14
|
4.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
72 |
26K |
17 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
72
|
26K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
72 |
26K |
18 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
72
|
26K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
72 |
26K |
13 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
72
|
26K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
158 |
44K |
4 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
Gan_Gans
|
224 |
54K |
4 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
54K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase III Clinical Trial Update and New IIH Market Analysis
|
|
Gan_Gans
|
224 |
54K |
3 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
224
|
54K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
Gan_Gans
|
3.5K |
1.0M |
3 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
3
|
|
ASX - By Stock
|
LKE |
Re:
Ann: Investor Operational Update
|
|
Gan_Gans
|
336 |
105K |
1 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
336
|
105K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
What do YOU choose?
|
|
Gan_Gans
|
51 |
18K |
1 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
51
|
18K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary and Secondary endpoints met in MPS I Trial
|
|
Gan_Gans
|
37 |
20K |
3 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
37
|
20K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary and Secondary endpoints met in MPS I Trial
|
|
Gan_Gans
|
37 |
20K |
10 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
37
|
20K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
Gan_Gans
|
124 |
37K |
0 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
124
|
37K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive outcomes in DMD combination therapy animal study
|
|
Gan_Gans
|
124 |
37K |
1 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
124
|
37K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial
|
|
Gan_Gans
|
34 |
12K |
3 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
34
|
12K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
Gan_Gans
|
98 |
29K |
18 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
98
|
29K
|
18
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
Gan_Gans
|
98 |
29K |
8 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
98
|
29K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Share price performance
|
|
Gan_Gans
|
28 |
10K |
4 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
28
|
10K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Kumagai, one of the Fantastic Four and some Mozz Firsts...
|
|
Gan_Gans
|
51 |
16K |
3 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
51
|
16K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Gan_Gans
|
4.2K |
3.8M |
12 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice - Rennie
|
|
Gan_Gans
|
34 |
12K |
6 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
34
|
12K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice - Rennie
|
|
Gan_Gans
|
34 |
12K |
1 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
34
|
12K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Gan_Gans
|
41 |
13K |
2 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
41
|
13K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Gan_Gans
|
41 |
13K |
2 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
41
|
13K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Gan_Gans
|
41 |
13K |
0 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
41
|
13K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Gan_Gans
|
41 |
13K |
1 |
14/05/23 |
14/05/23 |
ASX - By Stock
|
41
|
13K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Diamond’s last day at ANP
|
|
Gan_Gans
|
50 |
11K |
8 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
50
|
11K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Diamond’s last day at ANP
|
|
Gan_Gans
|
50 |
11K |
2 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
50
|
11K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Diamond’s last day at ANP
|
|
Gan_Gans
|
50 |
11K |
5 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
50
|
11K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Diamond’s last day at ANP
|
|
Gan_Gans
|
50 |
11K |
0 |
12/05/23 |
12/05/23 |
ASX - By Stock
|
50
|
11K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Gan_Gans
|
99 |
28K |
7 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
99
|
28K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Gan_Gans
|
99 |
28K |
9 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
99
|
28K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
Gan_Gans
|
99 |
28K |
10 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
99
|
28K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
The screen behind the scene...
|
|
Gan_Gans
|
41 |
13K |
0 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
41
|
13K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Gan_Gans
|
4.2K |
3.8M |
7 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Chief Executive Officer and Managing Director Appointment
|
|
Gan_Gans
|
107 |
28K |
2 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
107
|
28K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Chief Executive Officer and Managing Director Appointment
|
|
Gan_Gans
|
107 |
28K |
1 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
107
|
28K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
117 |
28K |
2 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
117
|
28K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Gan_Gans
|
117 |
28K |
2 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
117
|
28K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
PAR Broker Data
|
|
Gan_Gans
|
336 |
146K |
1 |
18/04/23 |
18/04/23 |
ASX - By Stock
|
336
|
146K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Gan_Gans
|
386 |
164K |
5 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
386
|
164K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Gan_Gans
|
386 |
164K |
3 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
386
|
164K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Gan_Gans
|
386 |
164K |
1 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
386
|
164K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Knock knock ! Is anyone there ?
|
|
Gan_Gans
|
6 |
2.5K |
3 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
6
|
2.5K
|
3
|
|